- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 17th, 2005
MTF and Asklepios Announce Collaboration
The Musculoskeletal Transplant Foundation (MTF), and Asklepios Biopharmaceutical Inc. (AskBio), a private development-stage biotechnology company, announced today that they have entered into a research collaboration to jointly develop and commercialize novel solutions to orthopedic tissue repair.
Through this collaboration, MTF gains access to AskBio’s extensive expertise in targeting and delivery of therapeutic genetic cargo to patients’ cells utilizing a platform technology, the Biological Nano Particle (BNPtm). AskBio’s BNPs have clinical advantages in delivering genetic therapeutic cargo to a platform of applications that MTF will apply to improve the performance of allograft in an array of orthopedic procedures.
|Related News Press|
Researchers predict material with record-setting melting point July 27th, 2015
Nanometrics Announces Upcoming Investor Events July 28th, 2015
Stretching the limits on conducting wires July 25th, 2015
Nanopaper as an optical sensing platform July 23rd, 2015